Name | N-{(3S,4S)-4-[4-(5-Methyl-2-thienyl)phenoxy]tetrahydro-3-furanyl}-2-propanesulfonamide |
---|---|
Synonyms |
N-{(3S,4S)-4-[4-(5-Methyl-2-thienyl)phenoxy]tetrahydro-3-furanyl}-2-propanesulfonamide
2-Propanesulfonamide, N-[(3S,4S)-tetrahydro-4-[4-(5-methyl-2-thienyl)phenoxy]-3-furanyl]- |
Description | PF-04958242 is a novel potent, selctive, and orally-active AMPA receptor (AMPAR) positive allosteric modulator (PAM) with Ki of 170 nM, EC50 of 370 nM; is under development for the treatment of cognitive symptoms in schizophrenia. Schizophrenia Phase 1 Discontinued |
---|---|
References | References 1. Shaffer CL, et al. J Med Chem. 2015 May 28;58(10):4291-308. 2. Ranganathan M, et al. Mol Psychiatry. 2017 Feb 28. doi: 10.1038/mp.2017.6. View Related Products by Target iGluR Schizophrenia |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 531.0±60.0 °C at 760 mmHg |
Molecular Formula | C18H20N2O4S2 |
Molecular Weight | 381.509 |
Flash Point | 275.0±32.9 °C |
Exact Mass | 381.106842 |
LogP | 3.22 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.603 |